The table below shows AVANOS MEDICAL, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$701.20M
$687.80M
$673.30M
$684.10M
$587.00M
$714.80M
Cost of revenue
$347.30M
$306.50M
$293.60M
$289.90M
$287.80M
$343.90M
Gross profit
$353.90M
$381.30M
$379.70M
$394.20M
$299.20M
$370.90M
R&D
$23.30M
$26.20M
$27.20M
$29.20M
$30.60M
$34.90M
AVNS annual revenue (10-K history)
AVANOS MEDICAL, INC. reported annual revenue of $701.20M for fiscal year 2025. That is up 1.9% from $687.80M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $566.20M (FY 2016) to $701.20M. Figures come from the company's audited annual reports as filed with the SEC.
